ENTX NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Entera Bio Ltd · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 2.99 USD
45.9% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 108.6% above the Trend Line and sits at 63.2% of its 52-week range. The latest completed week returned 45.9%, after a 80.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 53/100 conviction, while the latest news-sentiment score is 62/100. Near-term considerations: earnings are due in 7d.

Setup score 58 out of 100
Latest Close 2.99 USD 31 Jul 2026
1W Return 45.9% latest completed week
4W Return 80.1% short-term follow-through
12W Return 130.0% quarterly tape
Trend Breadth 23.1% 12 of 52 weeks active
Volume Ratio 7.7x vs 13-week average
What is working
  • The trend backdrop is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 35.02% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • 1 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 45.9% Latest completed week; four-week move 80.1%. Indicator stack 20/83 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 35.02% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 53/100 conviction; expected move 22.6%. News sentiment 62/100 50 relevant articles in the latest sentiment read. Event risk 7d Next report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 108.6% above the Trend Line and sits at 63.2% of its 52-week range. The latest completed week returned 45.9%, after a 80.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 7.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4012-week average 0.20

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.40Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers

No recent accumulation markers. 1 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 80.1% over four weeks, 130.0% over 12 weeks, and 53.3% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W45.9%
4W80.1%
12W130.0%
26W118.2%
52W53.3%
Active trend streak2 weeks
Active weeks in one year12
Trend breadth23.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.50Latest activity-pressure read.
Pressure change73.8%Four-week change in activity pressure.
Leadership55.94Latest relative-leadership reading.
RS change427.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 02 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 67% Model confidence 63%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength64/100Blend of value, momentum, and quality. Underlying universe rank 37; rank 1 is best.
Value56/100Relative valuation strength. Underlying universe rank 45; rank 1 is best.
Quality54/100Profitability and accounting quality. Underlying universe rank 47; rank 1 is best.
Momentum57/100Medium-term price momentum. Underlying universe rank 44; rank 1 is best.
Growth56/100Revenue and earnings growth. Underlying universe rank 45; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-6.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-132.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
-0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

ENTX shows volatility options pressure with a 53/100 conviction score, put-call volume ratio of 756.00, expected move of 22.6%, and Sharemaestro trend signal active.

Conviction53/100
Expected move22.6%
Put/call volume756.00
Pressure-100
Speculation8
Volatility96
Trend agreement0
Open options detail
Insider activity5 / 0

5 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment62/100

Weighted news tone is positive across 50 relevant articles.

26 positive · 22 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings7dNext report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
Options expected move22.6%Nearest-chain priced movement where available.
52-week drawdown-28.8%Distance below the 52-week high.
13-week volatility15.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+45.9%Week of 31 Jul.
Worst week-24.1%Week of 6 Feb.
Latest week+45.9%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains4
Flat weeks0
Modest losses6
Sharp losses7
Recent vol15.8%13-week weekly-return volatility.
Base vol14.9%52-week weekly-return volatility.
Up/down split23/28Count of positive and negative weeks in the 52-week window.
Average skew13.6% / -7.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape50/100

Trend, activity pressure, participation, and risk combine to a 50/100 tape read.

 Indicator analysis44/100

Latest 12-week confirmation: trend 2/12, activity pressure 12/12, relative leadership 3/12.

Activity pressure 0.40; 1 reversal markers Next-Week ExpectancyNegative 35.02%

Next-week expectancy is negative with a 35.02% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors57/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 70; Small Cap Core rank 51 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options36/100

ENTX shows volatility options pressure with a 53/100 conviction score, put-call volume ratio of 756.00, expected move of 22.6%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 22.6% Sentiment62/100

Weighted news tone is positive across 50 relevant articles.

Entera Bio CEO to speak at Canaccord Genuity Growth Conference on Aug 12, 2026 Insiders5 / 0

5 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings7d

Next report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20262.99 USD45.9%1.43 USD1.66 USD1.5055.9491.8MOn
24 Jul 20262.05 USD3.5%1.39 USD1.65 USD1.418.11943.8KOn
17 Jul 20261.98 USD19.6%1.38 USD1.64 USD1.412.541.4MOff
10 Jul 20261.66 USD-0.3%1.37 USD1.63 USD1.12-18.321.2MOff
3 Jul 20261.66 USD1.8%1.39 USD1.63 USD0.86-17.081.3MOff
26 Jun 20261.63 USD34.7%1.41 USD1.62 USD0.56-18.4855.5MOff
19 Jun 20261.21 USD-1.6%1.43 USD1.62 USD0.30-42.72255.1KOff
12 Jun 20261.23 USD4.2%1.48 USD1.61 USD0.23-41.07139.7KOff
5 Jun 20261.18 USD-12.6%1.53 USD1.61 USD0.23-42.85394.4KOff
29 May 20261.35 USD8.9%1.59 USD1.61 USD0.28-38.47463.4KOff
22 May 20261.24 USD-1.6%1.64 USD1.61 USD0.13-42.50223.1KOff
15 May 20261.26 USD-3.1%1.68 USD1.60 USD0.08-41.65487.2KOff
8 May 20261.30 USD18.2%1.71 USD1.60 USD0.09-40.79714.1KOff
1 May 20261.10 USD-1.8%1.76 USD1.60 USD-0.12-47.98683.4KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.